Xianju Pharmaceutical: Already has the independent production capacity of both dienogest and progesterone raw materials.

On September 17th, Xianju Pharmaceutical stated on the interactive platform that the company had obtained the domestic production drug registration certificate for Diosmin tablets in May 2025, and the company also has the independent production capability of Diosmin raw materials.